Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Xgeva® (denosumab) – New warning
January 24, 2018 - The FDA approved an update to the Warnings and Precautions section of the Xgeva (denosumab) drug label regarding multiple vertebral fractures (MVF) following treatment discontinuation.
